Sanofi Statistics

Share Statistics

Sanofi has 2.44B shares outstanding. The number of shares has increased by -2.81% in one year.

Shares Outstanding	2.44B
Shares Change (YoY)	-2.81%
Shares Change (QoQ)	-0.47%
Owned by Institutions (%)	10.59%
Shares Floating	2.44B
Failed to Deliver (FTD) Shares	683
FTD / Avg. Volume	0.03%

Short Selling Information

The latest short interest is 3.67M, so 0.15% of the outstanding shares have been sold short.

Short Interest	3.67M
Short % of Shares Out	0.15%
Short % of Float	0.17%
Short Ratio (days to cover)	1.98

Valuation Ratios

The PE ratio is 20.97 and the forward PE ratio is 9.84. Sanofi's PEG ratio is 3.23.

PE Ratio	20.97
Forward PE	9.84
PS Ratio	2.63
Forward PS	2.1
PB Ratio	1.5
P/FCF Ratio	19.8
PEG Ratio	3.23

Financial Ratio History

Enterprise Valuation

Sanofi has an Enterprise Value (EV) of 68.75B.

EV / Sales	1.55
EV / EBITDA	6.23
EV / EBIT	7.57
EV / FCF	11.68

Financial Position

The company has a current ratio of 1.46, with a Debt / Equity ratio of 0.23.

Current Ratio	1.46
Quick Ratio	1.14
Debt / Equity	0.23
Debt / EBITDA	1.62
Debt / FCF	3.04
Interest Coverage	9.68

Financial Efficiency

Return on Equity is 7.17% and Return on Invested Capital is 5.5%.

Return on Equity	7.17%
Return on Assets	4.19%
Return on Invested Capital	5.5%
Revenue Per Employee	$534.35K
Profits Per Employee	$67.09K
Employee Count	82,878
Asset Turnover	0.33
Inventory Turnover	1.4

Taxes

Income Tax	1.2B
Effective Tax Rate	17.98%

Stock Price Statistics

The stock price has increased by -9.54% in the last 52 weeks. The beta is 0.41, so Sanofi's price volatility has been higher than the market average.

Beta	0.41
52-Week Price Change	-9.54%
50-Day Moving Average	48.76
200-Day Moving Average	51.27
Relative Strength Index (RSI)	44.24
Average Volume (20 Days)	2,316,370

Income Statement

In the last 12 months, Sanofi had revenue of 44.29B and earned 5.56B in profits. Earnings per share was 2.3.

Revenue	44.29B
Gross Profit	31.08B
Operating Income	7.25B
Net Income	5.56B
EBITDA	11.03B
EBIT	7.45B
Earnings Per Share (EPS)	2.3

Full Income Statement

Balance Sheet

The company has 7.44B in cash and 17.91B in debt, giving a net cash position of -10.46B.

Cash & Cash Equivalents	7.44B
Total Debt	17.91B
Net Cash	-10.46B
Retained Earnings	n/a
Total Assets	124.96B
Working Capital	7.96B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 9.08B and capital expenditures -3.19B, giving a free cash flow of 5.89B.

Operating Cash Flow	9.08B
Capital Expenditures	-3.19B
Free Cash Flow	5.89B
FCF Per Share	2.35

Full Cash Flow Statement

Margins

Gross margin is 70.18%, with operating and profit margins of 16.38% and 12.55%.

Gross Margin	70.18%
Operating Margin	16.38%
Pretax Margin	15.12%
Profit Margin	12.55%
EBITDA Margin	24.91%
EBIT Margin	16.38%
FCF Margin	13.29%

Dividends & Yields

SNY pays an annual dividend of $4.25, which amounts to a dividend yield of 4.43%.

Dividend Per Share	$4.25
Dividend Yield	4.43%
Dividend Growth (YoY)	8.6%
Payout Ratio	142.59%
Earnings Yield	4.77%
FCF Yield	10.1%

Dividend Details

Analyst Forecast

The average price target for SNY is $65, which is 37.7% higher than the current price. The consensus rating is "Hold".

Price Target	$65
Price Target Difference	37.7%
Analyst Consensus	Hold
Analyst Count	2

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	$11.5
Lynch Upside	-75.64%
Graham Number	78.69
Graham Upside	66.72%

Stock Splits

The last stock split was on Sep 30, 2013. It was a forward split with a ratio of 5:1.

Last Split Date	Sep 30, 2013
Split Type	forward
Split Ratio	5:1

Scores

Altman Z-Score	1.89
Piotroski F-Score	6

Sanofi (SNY)